Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,626,825
+$173,618 QoQ
Shares Held
18,218
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.23%
of 13F equity value
Holder Rank
#1,677
of 4,676 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $26,299,020 across 9 Drug Manufacturers - General names. JNJ ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,354 | $7,621,178 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
18,218 | $4,626,825 | |
| 3 | AMGN |
Amgen Inc
|
9,210 | $3,335,125 | |
| 4 | ABBV |
AbbVie Inc.
|
12,200 | $3,070,008 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,480 | $2,760,180 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
20,620 | $2,605,130 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
21,150 | $1,218,663 | |
| 8 | PFE |
Pfizer Inc
|
27,500 | $662,200 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,626,825 | 18,218 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,453,207 | 18,218 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,201,085 | 20,300 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,836,926 | 15,300 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,948,075 | 19,300 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,615,312 | 21,800 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,311,798 | 22,900 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,197,354 | 25,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,309,196 | 56,850 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,569,391 | 47,850 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,440,449 | 53,850 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,854,387 | 56,850 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,278,792 | 62,100 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $9,625,500 | 62,100 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,969,965 | 62,100 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $11,083,976 | 67,850 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,044,053 | 67,850 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,893,482 | 72,750 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $12,744,715 | 74,500 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $12,031,750 | 74,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,943,650 | 72,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,915,375 | 72,500 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,724,810 | 74,500 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $11,091,560 | 74,500 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||